Logo Lanfrica
  • Accueil
  • Atlas
  • Analyses
  • Documentation
  • Sign in

© 2026 Lanfrica. Tous droits réservés. Tous les droits d'auteur des ressources affichées sur le site Web Lanfrica appartiennent aux détenteurs de droits d'auteur d'origine, sauf indication contraire explicite.

Following Guidelines for Drug-Resistant Tuberculosis: “Yes, it’s a challenge”

Domaine:

healthcare

Type de record:

paper
Créateur:
AdaCarTomSus
Éditeur:
Fro
Hôte:
Background Drug-resistant tuberculosis (DR-TB) is a major contributor to antimicrobial resistance (AMR) globally and is projected to be responsible for up to a quarter of AMR-associated deaths in the future. Management of DR-TB is increasingly decentralised to primary healthcare settings, and simultaneously becoming more complex due to a growing range of treatment options (e.g. novel agents, shorter regimens). This is reflected in the numerous recent updates to international guidelines and as such understanding the barriers and enablers to how healthcare workers access and use guidelines is vital. Materials and Methods We used an established psychological framework – the theoretical domains framework (TDF) – to construct and analyse an online survey and focus groups to explore healthcare workers current use of DR-TB guidelines in South Africa. We aimed to identify barriers and enablers with which to direct future attempts at improving guideline use. Results There were 19 responses to the online survey and 14 participants in two focus groups. 28% used the most up-to-date national guidelines, 79% accessed guidelines primarily on electronic devices. The TDF domains of ‘Social Influences’ (mean Likert score = 4.3) and ‘Beliefs about Consequences’ (4.2) were key enablers, with healthcare workers encouraged to use guidelines and also recognising the value in doing so. ‘Environmental Resources’ (3.7) and ‘Knowledge’ (3.3) were key barriers with limited, or variable access to guidelines and lack of confidence using them being notable issues. This was most noted for certain subgroups: children, HIV co-infected, pregnant women (2.7). Discussion Current use of DR-TB guidelines in South Africa is suboptimal. Planned interventions should focus on overcoming the identified key barriers and might include an increased use of digital tools.

Visit

doi.org

Licenses

https://creativecommons.org/licenses/by/4.0/

Similaires

Addressing the drug-resistant tuberculosis challenge through implementing a mixed model of care in UgandaAddressing the drug resistant tuberculosis challenge through implementing a mixed model of care in Uganda, 2012- 2017Replication Study: Quantifying the Time-to-Treatment Initiation for Multi-Drug Resistant Tuberculosis Following Diagnostic Decentralisation in Nigeria, 2001Risk factors for mortality among drug-resistant tuberculosis patients registered for drug-resistant treatment in Amhara region, Ethiopia: a historical cohort studyPrevalence of Multi Drug Resistant Tuberculosis among Presumptive Multi Drug Resistant Tuberculosis Cases in Amhara National Regional State, EthiopiaBudgetary impact of using BPaL for treating extensively drug-resistant tuberculosis

Addressing the drug-resistant tuberculosis challenge through implementing a mixed model of care in Uganda

Worldwide, Drug-resistant Tuberculosis (DR-TB) remains a big problem; the diagnostic capacity has su

Addressing the drug resistant tuberculosis challenge through implementing a mixed model of care in Uganda, 2012- 2017

Abstract Background Worldwide, Drug resistant Tuberculosis (DR-TB) remains a big problem;

Replication Study: Quantifying the Time-to-Treatment Initiation for Multi-Drug Resistant Tuberculosis Following Diagnostic Decentralisation in Nigeria, 2001

Decentralising multi-drug resistant tuberculosis (MDR-TB) diagnosis to regional hospitals was a key

Risk factors for mortality among drug-resistant tuberculosis patients registered for drug-resistant treatment in Amhara region, Ethiopia: a historical cohort study

Abstract Background The emergency of drug resistant tuberculosi

Prevalence of Multi Drug Resistant Tuberculosis among Presumptive Multi Drug Resistant Tuberculosis Cases in Amhara National Regional State, Ethiopia

Budgetary impact of using BPaL for treating extensively drug-resistant tuberculosis

Introduction Bedaquiline, pretomanid and linezolid (BPaL) is a new all oral, 6-m